Skip to main content
logo
Foghorn Therapeutics Inc. (FHTX)
NASDAQ: FHTX · Real-Time Price · USD
4.680
-0.080 (-1.68%)
May 4, 2026, 4:00 PM EDT - Market closed

Foghorn Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
275306262273267945
Market Cap Growth
42.36%16.59%-3.78%2.25%-71.76%26.65%
Enterprise Value
158.27187.446.7275.22-33.56841.57
Last Close Price
4.685.404.726.456.3822.87
PE Ratio
--4.58-2.99-2.76-2.44-8.38
PS Ratio
8.939.9011.617.9813.87716.09
PB Ratio
--2.82-5.76-3.532381.309.75
P/TBV Ratio
-2.72-3.13-5.69-3.512369.238.78
P/FCF Ratio
--3.55-2.59-2.291.39-17.63
P/OCF Ratio
--3.55-2.61-2.311.38-18.80
EV/Sales Ratio
5.126.062.072.20-1.75638.04
EV/EBITDA Ratio
--2.26-0.47-0.720.29-8.63
EV/EBIT Ratio
--2.17-0.46-0.700.29-8.35
EV/FCF Ratio
--2.18-0.46-0.63-0.17-15.71
Debt / Equity Ratio
-0.37-0.37-0.62-0.47406.580.53
Debt / EBITDA Ratio
-0.50-0.50-0.37-0.43-0.45-0.60
Debt / FCF Ratio
-0.48-0.48-0.37-0.380.27-1.09
Net Debt / Equity Ratio
1.081.084.542.45-2627.60-0.99
Net Debt / EBITDA Ratio
1.421.422.081.812.590.98
Net Debt / FCF Ratio
1.371.372.041.58-1.531.79
Asset Turnover
0.130.130.080.100.040.00
Quick Ratio
2.662.663.644.016.263.17
Current Ratio
2.732.733.734.116.379.44
Return on Equity (ROE)
96.45%96.45%141.17%233.46%-224.54%-81.34%
Return on Assets (ROA)
-35.84%-35.84%-36.04%-29.84%-25.34%-25.98%
Return on Invested Capital (ROIC)
-335.46%-335.46%-318.84%-260.39%-59.34%-49.25%
Return on Capital Employed (ROCE)
-48.62%-48.62%-46.20%-37.39%-28.54%-28.46%
Earnings Yield
-26.92%-21.85%-33.47%-36.28%-41.07%-11.94%
FCF Yield
-31.23%-28.16%-38.61%-43.76%72.14%-5.67%
Buyback Yield / Dilution
-14.72%-14.72%-30.79%-0.92%-11.89%0.00%
Total Shareholder Return
-14.72%-14.72%-30.79%-0.92%-11.89%0.00%
Updated Mar 11, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q